Natera to Report its Third Quarter Results on November 6, 2025

Audio By Carbonatix

AUSTIN, Texas--(BUSINESS WIRE)--Oct 30, 2025--

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will release results for its third quarter ended September 30, 2025, after the market closes on November 6, 2025. Natera will host a conference call and webcast shortly thereafter at 4:30 p.m. ET.

A webcast replay will be available at investor.natera.com.

About Natera

Natera™ is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 325 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251030336447/en/

CONTACT: Investor Relations: Mike Brophy, CFO, Natera, Inc.,[email protected]

Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc.,[email protected]

KEYWORD: TEXAS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: WOMEN ONCOLOGY PUBLIC RELATIONS/INVESTOR RELATIONS GENERAL HEALTH HEALTH COMMUNICATIONS GENETICS CONSUMER

SOURCE: Natera, Inc.

Copyright Business Wire 2025.

PUB: 10/30/2025 07:00 AM/DISC: 10/30/2025 07:00 AM

http://www.businesswire.com/news/home/20251030336447/en